AQR Capital Management
CLOV icon

AQR Capital Management’s Clover Health Investments CLOV Stock Holding History

AQR Capital Management’s Portfolio CLOV Stock Details CLOV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.56M Buy
488,182
+382,993
+364% +$1.3M ﹤0.01% 2461
2026
Q1 		$185K Buy
105,189
+88,895
+546% +$193K ﹤0.01% 3611
2025
Q4 		$38.3K Sell
16,294
-29,936
-65% -$81.8K ﹤0.01% 3524
2025
Q3 		$141K Buy
46,230
+28,476
+160% +$81.3K ﹤0.01% 3323
2025
Q2 		$49.5K Buy
17,754
+4,178
+31% +$13.7K ﹤0.01% 3238
2025
Q1 		$48.7K Buy
+13,576
New +$54.5K ﹤0.01% 3082
2024
Q3 		– Sell
-729,706
Closed -$898K – 2779
2024
Q2 		$898K Buy
729,706
+32,288
+5% +$29K ﹤0.01% 1798
2024
Q1 		$554K Buy
697,418
+195,396
+39% +$178K ﹤0.01% 1927
2023
Q4 		$478K Sell
502,022
-286,390
-36% -$281K ﹤0.01% 1899
2023
Q3 		$851K Buy
788,412
+333,868
+73% +$397K ﹤0.01% 1652
2023
Q2 		$408K Sell
454,544
-96,627
-18% -$85.7K ﹤0.01% 1842
2023
Q1 		$466K Sell
551,171
-32,295
-6% -$35.4K ﹤0.01% 1804
2022
Q4 		$542K Buy
+583,466
New +$779K ﹤0.01% 1786

Other funds holding CLOV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $751B AUM 38.74% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
PNC Financial Services Group
PNC Financial Services Group Pittsburgh, Pennsylvania $202B AUM 37.79% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

AQR Capital Management's CLOV Position: Q2 2026 in Review

AQR Capital Management increased its Clover Health Investments (CLOV) stake by 364% in Q2 2026, buying an estimated $1.3M and bringing the position to 488,182 shares worth $2.56M. The position accounts for ﹤0.01% of the portfolio, ranked #2461.

AQR Capital Management first reported a position in CLOV in Q4 2022 and has held it in 13 quarters since. 225 funds tracked by Wall St. Rank hold CLOV as of Q2 2026.

  • AQR Capital Management held 488,182 shares of Clover Health Investments worth $2.56M as of Q2 2026.
  • AQR Capital Management bought 382,993 Clover Health Investments shares in Q2 2026, an estimated $1.3M.
  • Clover Health Investments made up ﹤0.01% of AQR Capital Management's portfolio in Q2 2026, its #2461 holding.
  • AQR Capital Management first reported a position in Clover Health Investments in Q4 2022 and has held it in 13 quarters since.
  • 225 funds tracked by Wall St. Rank held Clover Health Investments as of Q2 2026.

Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.